Jul 29, 2024 / 03:00PM GMT
Operator
Good afternoon. This is the chorus call conference operator. Welcome, and thank you for joining the DiaSorin second quarter 2024 results conference call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Carlo Rosa - DiaSorin SpA - Chief Executive Officer, Executive Director, General Manager
Thank you, operator. Good morning, good afternoon to everybody, and welcome to the quarter two 2024 results. I'm going to make some introductory comments first at constant exchange rate, and then I'm going to leave Mr. Pedron, the CFO of the company, to go through the numbers in more detail.
So let's start from the topline. It was a strong quarter. The company ex-COVID grew 7%, and there is an acceleration in quarter two compared to quarter one. When it comes to the COVID business, EUR5 million in the quarter, so far in line with our full-year guidance of EUR30 million. In fact, it's a very strong quarter, and it's a combination of immunoassay that is growing 11% and
Half Year 2024 DiaSorin SpA Earnings Call Transcript
Jul 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers